Flagship Pioneering Inc. Portfolio Holdings

Flagship Pioneering Inc.

  • $256 Million
  • Q2 2025

Flagship Pioneering Inc. has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $256 Million distributed in 8 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Moderna, Inc. with a value of $128M, Sana Biotechnology, Inc. with a value of $68.3M, Foghorn Therapeutics Inc. with a value of $59.6M, and Seres Therapeutics Inc with a value of $0.

Examining the 13F form we can see an increase of $19.9M in the current position value, from $236M to 256M.

Flagship Pioneering Inc. is based out at Cambridge, MA

Below you can find more details about Flagship Pioneering Inc. portfolio as well as his latest detailed transactions.

Portfolio value $256 Million
Healthcare: $256 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$10B
$128 Million 50.0% of portfolio
4,632,149
Q2 2024 Reduced 52.08%
$592M
$68.3 Million 26.7% of portfolio
25,001,856
Q4 2023 Reduced 24.9%
$203M
$59.6 Million 23.3% of portfolio
12,674,120
Q4 2020 New

Summary

  • Portfolio
  • No. of Stocks 8
  • Current Value $256 Million
  • Prior Value $236 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Flagship Pioneering Inc. Portfolio

Follow Flagship Pioneering Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Pioneering Inc., based on Form 13F filings with the SEC.

News

Stay updated on Flagship Pioneering Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email